PureTech Health plc
PRTC · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.00 | -0.04 | -0.07 |
| FCF Yield | -11.34% | -10.92% | -12.24% | -5.26% |
| EV / EBITDA | -3.57 | 2.35 | -7.59 | -53.28 |
| Quality | ||||
| ROIC | -9.40% | -11.92% | -13.03% | -19.95% |
| Gross Margin | -1,245.22% | 1,066.67% | -13,416.67% | -940.00% |
| Cash Conversion Ratio | 1.03 | -0.78 | 1.92 | 0.61 |
| Growth | ||||
| Revenue 3-Year CAGR | -34.91% | -29.22% | -27.03% | -14.17% |
| Free Cash Flow Growth | 15.49% | 32.05% | -99.46% | 38.48% |
| Safety | ||||
| Net Debt / EBITDA | 5.18 | -2.53 | 2.54 | 14.99 |
| Interest Coverage | -50.24 | 52.05 | -5.84 | -8.24 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 657.07 | 301.14 | 623.40 | 488.23 |